Parkinson’s Disease could be diagnosed with skin swab tests, Manchester scientists discover
Scientists at the University of Manchester have made a “game-changing” breakthrough by discovering that Parkinson’s Disease could be diagnosed using a simple skin swab test.
Scientists at the University of Manchester have made a “game-changing” breakthrough by discovering that Parkinson’s Disease could be diagnosed using a simple skin swab test.
Results published this week showed that Parkinson’s sufferers may produce higher amounts of a substance called sebum – which coats and protects the skin.
A swab test can detect these compounds; and may help researchers determine whether new treatments are able to slow, stop or reverse the progression of the disease.
The study was funded following the case of Joy Milne – a woman who stunned scientists by revealing she could detect Parkinson’s disease through smell.
Joy told researchers that she could smell a “musky” odour on her husband Les – who was diagnosed with Parkinson’s years later.
Professor Perdita Barran, Professor of Mass Spectrometry at UoM, said the results were “an extremely encouraging step” towards tests that could be used to help diagnose and monitor Parkinson’s.
ADVERTISEMENT
“Not only is the test quick, simple and painless but it should also be extremely cost-effective because it uses existing technology that is already widely available,” said the professor.
“We are now looking to take our findings forwards to refine the test to improve accuracy even further and to take steps towards making this a test that can be used in the NHS and to develop more precise diagnostics and better treatment for this debilitating condition.”
Parkinson’s can be difficult to diagnose / Image: Pixabay
Parkinson’s UK analysis suggests that 1 in 37 people will be diagnosed with Parkinson’s in their lifetime.
ADVERTISEMENT
The onset of the disease – which sees the sufferer develop a range of physical symptoms such as tremors and stiff, slow movements – is often gradual; worsening over a period of months and years.
The condition can be difficult to diagnose, too.
In a recent survey of more than 2,000 people with Parkinson’s, more than a quarter revealed they were initially misdiagnosed with a different condition.
It took four years for Daxa Kalayci, 56, to be given an accurate diagnosis of Parkinson’s.
“Despite my diagnosis eventually being confirmed by a DaTscan, a quick and simple diagnostic test for Parkinson’s would have given me the chance to start my treatment earlier and enjoy life a lot more,” said Daxa.
ADVERTISEMENT
“But instead, I lost so many years not being able to pursue a career as a paramedic or go back to nursing.
“This test could be a game-changer for people living with Parkinson’s and searching for answers like I was.”
Professor David Dexter, Associate Director of Research at Parkinson’s UK said that two more people in the UK are diagnosed with Parkinson’s every hour – and the COVID-19 pandemic has increased complications with regards to delays and misdiagnoses.
However, he called the new results “significant” in the bid to revolutionise Parkinson’s treatment.
The Professor added: “With this innovative test, we could see people being diagnosed quickly and accurately enabling them to access vital treatment and support to manage their Parkinson’s symptoms sooner.”
News
New ‘cutting-edge’ cancer treatment to be rolled out on NHS from next week
Emily Sergeant
A new ‘cutting-edge’ cancer treatment is set to be rolled out on the NHS from next week.
Thousands of men with prostate cancer are to be offered high-powered ‘precision’ radiotherapy on the NHS to target the disease more effectively – helping reduce side-effects and spare them 15 courses of treatment.
The highly targeted SABR (stereotactic ablative radiotherapy) delivers radiotherapy to the tumour from many different directions to help reduce the risk of cancer spreading or returning.
SABR has been proven to be effective at far fewer doses than conventional radiotherapy.
Standard radiotherapy can often be a major burden for patients and loved ones, due to the substantial treatment and travel time involved, but SABR is typically delivered in just five doses within a fortnight, compared to at least 20 doses with external beam radiotherapy.
Thousands of men with prostate cancer are to be offered high-powered ‘precision’ radiotherapy on the NHS to target the disease more effectively, helping reduce side-effects and spare them 15 courses of treatment.
Around 17,500 men are diagnosed with low or intermediate risk prostate cancer in England each year and could be offered the option of SABR radiotherapy.
It is expected that the cutting-edge technique for localised prostate cancer will be offered at all 48 radiotherapy providers across England in the coming days – with the first centres making it available on the NHS from next week.
The roll-out could free up around 50,000 appointments for prostate cancer treatment each year, helping the NHS continue to bring down waiting times for patients.
NHS chief executive, Sir Jim Mackey, said the news will ‘transform’ treatment for thousands of men with localised prostate cancer.
“This cutting-edge approach will transform treatment for thousands of men with prostate cancer, helping the NHS provide far more powerful and convenient care to stop their cancer spreading,” Sir Mackey commented.
“Having been proven effective in keeping cancer under control, this technology will not only help reduce the risk of certain side effects but also the major ‘to-and-fro’ burden of hospital treatment, which can be really draining for so many patients and their families.”
Featured Image – Accuray (via Unsplash)
News
Ryanair is being investigated over charging parents to sit with their children
Emily Sergeant
Ryanair is being investigated by the Government’s leading regulator over charging parents to sit with their children.
Currently, Ryanair’s terms and conditions require at least one parent to sit with their children aged two-11 when they fly, but this is done through what the airline calls a ‘mandatory family seat’, meaning the parent must pay in order for them to secure a seat next to their child.
This fee applies to both outbound and return flights, and typically costs around £8 each way – but for all other passengers, reserving a seat is optional.
And it’s this that the Competition and Markets Authority (CMA) has launched an investigation.
We’re investigating Ryanair over its practice of charging parents to sit with their children – including those with disabilities – and whether this could be unfair under consumer protection law.
— Competition & Markets Authority (@CMAgovUK) June 11, 2026
CMA evidence suggests this approach to seating is used across the majority of Ryanair’s UK routes, and the watchdog understands that Ryanair is the only major airline flying out of the UK to impose this charge.
Other airlines offer to seat children with a parent or guardian without the need for a paid-for adult seat reservation, or they allocate seats together automatically during booking for free.
The CMA says it’s investigating, in particular, whether Ryanair’s approach to seat reservations may mean parents are being charged for the airline to meet its child safety and disability‑related obligations as set out under aviation rules.
The watchdog wants to determine whether or not this practice is in line with consumer law, and whether the airline’s contract terms are ‘unfair’ if they put customers at an unfair disadvantage.
Ryanair is being investigated over charging parents to sit with their children / Credit: Gerrie van der Walt (via Unsplash)
Under consumer law, businesses must show a total price that includes all unavoidable charges, rather than adding extra charges separately or later in the process, as this ensures consumers can effectively compare prices and understand the true cost of what they are buying.
“Lots of families save up to afford a summer holiday and we know that extra charges can quickly bump up the price,” commented Hayley Fletcher, who is the Senior Director of Consumer Protection at the CMA.
“Our investigation will consider Ryanair’s approach to family seat reservations and how the cost is presented to consumers to determine whether they comply with consumer law.
“For the past year, we’ve told businesses to ensure their customers are shown the total price upfront – those who don’t face the very real possibility of action from the CMA.”
At present, the CMA is currently at the beginning of its investigation, and has reached no conclusions about whether Ryanair has broken the law.